- call +1-201-465-4211
- email sales@mrinsights.biz
HIV Diagnosis are used to detect the presence of the human immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome (AIDS), in serum, saliva, or urine. Such tests may detect antibodies, antigens, or RNA.
Scope of the Report:
This report studies the HIV Diagnosis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the HIV Diagnosis market by product type and applications/end industries.
The antibody tests segment is expected to account for the largest share of the market in 2016. This large share can be attributed to high prevalence of HIV/AIDS, increasing awareness about HIV/AIDS, increasing blood donations and advancements, and better offerings from PoC testing.
The diagnostic laboratories segment is expected to account for the largest share of market in 2018. This large share is mainly due to high investment and technological advancements of diagnostics laboratories and increasing awareness of HIV/AIDS
The global HIV Diagnosis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of HIV Diagnosis.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Siemens Healthineers
Roche Diagnostics
Abbott Laboratories
Beckman Coulter
Thermo Fisher
Merck
Becton, Dickinson
Hologic
Alere
Bio-Rad Laboratories
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
Market Segment by Applications, can be divided into
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 HIV Diagnosis Market Overview
1.1 Product Overview and Scope of HIV Diagnosis
1.2 Classification of HIV Diagnosis by Types
1.2.1 Global HIV Diagnosis Revenue Comparison by Types (2017-2023)
1.2.2 Global HIV Diagnosis Revenue Market Share by Types in 2017
1.2.3 Antibody Tests
1.2.4 Viral Load Tests
1.2.5 CD4 Tests
1.2.6 Tests for Early Infant Diagnosis
1.2.7 Tests for Viral Identification
1.3 Global HIV Diagnosis Market by Application
1.3.1 Global HIV Diagnosis Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.3.4 Blood Banks
1.3.5 Home Care Settings
1.3.6 Others
1.4 Global HIV Diagnosis Market by Regions
1.4.1 Global HIV Diagnosis Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) HIV Diagnosis Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) HIV Diagnosis Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) HIV Diagnosis Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) HIV Diagnosis Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) HIV Diagnosis Status and Prospect (2013-2023)
1.5 Global Market Size of HIV Diagnosis (2013-2023)
2 Manufacturers Profiles
2.1 Siemens Healthineers
2.1.1 Business Overview
2.1.2 HIV Diagnosis Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Siemens Healthineers HIV Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche Diagnostics
2.2.1 Business Overview
2.2.2 HIV Diagnosis Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Diagnostics HIV Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.3 Abbott Laboratories
2.3.1 Business Overview
2.3.2 HIV Diagnosis Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Abbott Laboratories HIV Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.4 Beckman Coulter
2.4.1 Business Overview
2.4.2 HIV Diagnosis Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Beckman Coulter HIV Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.5 Thermo Fisher
2.5.1 Business Overview
2.5.2 HIV Diagnosis Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Thermo Fisher HIV Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck
2.6.1 Business Overview
2.6.2 HIV Diagnosis Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck HIV Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.7 Becton, Dickinson
2.7.1 Business Overview
2.7.2 HIV Diagnosis Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Becton, Dickinson HIV Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.8 Hologic
2.8.1 Business Overview
2.8.2 HIV Diagnosis Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Hologic HIV Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.9 Alere
2.9.1 Business Overview
2.9.2 HIV Diagnosis Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Alere HIV Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.10 Bio-Rad Laboratories
2.10.1 Business Overview
2.10.2 HIV Diagnosis Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Bio-Rad Laboratories HIV Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
3 Global HIV Diagnosis Market Competition, by Players
3.1 Global HIV Diagnosis Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 HIV Diagnosis Players Market Share
3.2.2 Top 10 HIV Diagnosis Players Market Share
3.3 Market Competition Trend
4 Global HIV Diagnosis Market Size by Regions
4.1 Global HIV Diagnosis Revenue and Market Share by Regions
4.2 North America HIV Diagnosis Revenue and Growth Rate (2013-2018)
4.3 Europe HIV Diagnosis Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific HIV Diagnosis Revenue and Growth Rate (2013-2018)
4.5 South America HIV Diagnosis Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa HIV Diagnosis Revenue and Growth Rate (2013-2018)
5 North America HIV Diagnosis Revenue by Countries
5.1 North America HIV Diagnosis Revenue by Countries (2013-2018)
5.2 USA HIV Diagnosis Revenue and Growth Rate (2013-2018)
5.3 Canada HIV Diagnosis Revenue and Growth Rate (2013-2018)
5.4 Mexico HIV Diagnosis Revenue and Growth Rate (2013-2018)
6 Europe HIV Diagnosis Revenue by Countries
6.1 Europe HIV Diagnosis Revenue by Countries (2013-2018)
6.2 Germany HIV Diagnosis Revenue and Growth Rate (2013-2018)
6.3 UK HIV Diagnosis Revenue and Growth Rate (2013-2018)
6.4 France HIV Diagnosis Revenue and Growth Rate (2013-2018)
6.5 Russia HIV Diagnosis Revenue and Growth Rate (2013-2018)
6.6 Italy HIV Diagnosis Revenue and Growth Rate (2013-2018)
7 Asia-Pacific HIV Diagnosis Revenue by Countries
7.1 Asia-Pacific HIV Diagnosis Revenue by Countries (2013-2018)
7.2 China HIV Diagnosis Revenue and Growth Rate (2013-2018)
7.3 Japan HIV Diagnosis Revenue and Growth Rate (2013-2018)
7.4 Korea HIV Diagnosis Revenue and Growth Rate (2013-2018)
7.5 India HIV Diagnosis Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia HIV Diagnosis Revenue and Growth Rate (2013-2018)
8 South America HIV Diagnosis Revenue by Countries
8.1 South America HIV Diagnosis Revenue by Countries (2013-2018)
8.2 Brazil HIV Diagnosis Revenue and Growth Rate (2013-2018)
8.3 Argentina HIV Diagnosis Revenue and Growth Rate (2013-2018)
8.4 Colombia HIV Diagnosis Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue HIV Diagnosis by Countries
9.1 Middle East and Africa HIV Diagnosis Revenue by Countries (2013-2018)
9.2 Saudi Arabia HIV Diagnosis Revenue and Growth Rate (2013-2018)
9.3 UAE HIV Diagnosis Revenue and Growth Rate (2013-2018)
9.4 Egypt HIV Diagnosis Revenue and Growth Rate (2013-2018)
9.5 Nigeria HIV Diagnosis Revenue and Growth Rate (2013-2018)
9.6 South Africa HIV Diagnosis Revenue and Growth Rate (2013-2018)
10 Global HIV Diagnosis Market Segment by Type
10.1 Global HIV Diagnosis Revenue and Market Share by Type (2013-2018)
10.2 Global HIV Diagnosis Market Forecast by Type (2018-2023)
10.3 Antibody Tests Revenue Growth Rate (2013-2023)
10.4 Viral Load Tests Revenue Growth Rate (2013-2023)
10.5 CD4 Tests Revenue Growth Rate (2013-2023)
10.6 Tests for Early Infant Diagnosis Revenue Growth Rate (2013-2023)
10.7 Tests for Viral Identification Revenue Growth Rate (2013-2023)
11 Global HIV Diagnosis Market Segment by Application
11.1 Global HIV Diagnosis Revenue Market Share by Application (2013-2018)
11.2 HIV Diagnosis Market Forecast by Application (2018-2023)
11.3 Diagnostic Laboratories Revenue Growth (2013-2018)
11.4 Hospitals Revenue Growth (2013-2018)
11.5 Blood Banks Revenue Growth (2013-2018)
11.6 Home Care Settings Revenue Growth (2013-2018)
11.7 Others Revenue Growth (2013-2018)
12 Global HIV Diagnosis Market Size Forecast (2018-2023)
12.1 Global HIV Diagnosis Market Size Forecast (2018-2023)
12.2 Global HIV Diagnosis Market Forecast by Regions (2018-2023)
12.3 North America HIV Diagnosis Revenue Market Forecast (2018-2023)
12.4 Europe HIV Diagnosis Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific HIV Diagnosis Revenue Market Forecast (2018-2023)
12.6 South America HIV Diagnosis Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa HIV Diagnosis Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure HIV Diagnosis Picture
Table Product Specifications of HIV Diagnosis
Table Global HIV Diagnosis and Revenue (Million USD) Market Split by Product Type
Fi
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
